Pharmacyclics buy melinda
Start price
08.12.12
/
50%
€44.20
Target price
10.06.13
€47.00
Performance (%)
49.54%
End price
10.06.13
€66.10
Summary
This prediction ended on 10.06.13 with a price of €66.10. The BUY prediction by melinda for Pharmacyclics saw massive gains of 49.54%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Pharmacyclics | - | - | - | - |
| iShares Core DAX® | 0.463% | -1.999% | 9.981% | 58.545% |
| iShares Nasdaq 100 | -1.792% | -5.743% | -0.781% | 80.511% |
| iShares Nikkei 225® | 5.124% | 9.091% | 28.823% | 62.776% |
| iShares S&P 500 | -1.760% | -3.669% | -0.543% | 54.389% |
Comments by melinda for this prediction
In the thread Pharmacyclics diskutieren
Biopharma
Pharmacyclics biopharmazeutisches Unternehmen in der Forschung, Entwicklung innovativer Medikamente gegen Krebs klinischen Studien Blood on Track spezialisiert
(Laufzeit überschritten)